Jobs
View more job listings or post a job
Gate Bioscience Director of Toxicology
Nura Bio Director of Toxicology
Nura Bio Vice President of CMC
MilliporeSigma Emerging Biotech Market Development Manager - San Fransisco
How Cancer LLC Social Media Digital Marketing Specialist  
How Cancer LLC Syndicated National Writer - Cancer 
University of California, Davis SCREENING SUPERVISOR
InnoAlliance Scientist/Sr Scientist of Bioanalysis & Biomarkers
Post a job

Workshop

[In-Person] Cell Therapy Discovery and Development: Fundamentals, Strategies and Best Practices (jointly by PBSS and RAPS-SF)


Speakers: Katy Spink, Dark Horse Consulting Group; Simona Zompì, CARGO Therapeutics; Shon Green, Adicet Bio; Toufan Parman, Sangamo Therapeutics; So-Ching Brazer, Adicet Bio
Organizers: Yoshiko Stowell, PhD (Kenai Therapeutics) and Toufan Parman, PhD, DABT (Sangamo Therapeutics)
Date: 2025-04-09
Time: 8:45-17:00 Pacific Time
Registration fee: Regular attendees: $295; Academic/Students/Postdocs/Out-of-Pocket: $45; Major Sponsorship: $3000; Vendor Show: $750, Happy Hour Sponsorship: $1250; Lunch Sponsorship: $1500; On-site Registration: $500
Location: Crowne Plaza, Foster City, CA (San Francisco Bay Area)
Major Sponsor:
Vendor show vendors registered to date: (6)BioTether Sciences; KACTUS; KYINNO BIOTECHNOLOGY (BOSTON) INC; Meadowhawk Biolabs; Novabiosis, Inc; Promega corporation
Registration: http://www.PBSS.org
Registration deadline:2025-04-08  (it will close sooner if the seating cap is reached)

About the Topic

This full day workshop will focus on cell therapy discovery and development topics. Starting with the fundamentals, overall regulatory strategies, and industry’s landscape, it aims to deepen participant’s knowledge on discovery, nonclinical strategies including an overview of genotoxicity and carcinogenicity of lentiviral vectors, CMC/QA strategies and clinical strategies.

List of Topics:

  • Overview of Cell Therapy: Fundamentals, regulatory pathways/strategies, and state of the industry’ landscape
  • Discovery of cell therapies
  • Nonclinical strategies
  • Genotoxicity and carcinogenicity of cell therapies
  • CMC/QA strategies: manufacturing, analytical/release
  • Clinical strategies


2025-02-26, [In-Person] Demystifying Biopharma Business Development: Understanding the Process and Thriving as a BD Professional
2025-03-07, [In-Person] Clinical Trial Planning and Conduct: Fundamentals, Strategies and Best Practices
2025-03-27, [Free Online Workshop] Biotech Financing 101: from Angels, Government Agencies, Foundations and VCs
2025-04-01, [For vendors ONLY] Seattle PBSS Seminar Luncheon Vendor Show
2025-04-22, [Free Online Workshop] Career Transitions for Research Scientists: BD/Sales in CROs, CDMOs, and Lab Products & Instruments
2025-04-25, [In-Person] Drug Metabolism Fundamentals and Metabolite Identification
2025-05-05, [Free Online] Highlights of 2024 FDA Drug Approvals
2025-05-12, [In-Person] Preclinical Pharmacology Studies and Translational Medicine for Drug Discovery and Development
2025-06-02, [In-Person] Metabolism and Transport-mediated Drug-Drug Interaction: Current Practices, Regulatory Guidances, and Their Impact on Drug Development
©Pharmaceutical & BioScience Society, International; Last Modified: 2/13/2025; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Allucent Experts bringing development innovation w/ClinPharm Modeling & Simulation deliverables to inform dose, study design, modeling+development strategies.
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Submit a Text Ad